References
- DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
- HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
- MiravitllesMCalleMSoler-CataluñaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol2012483869822196477
- GibsonPGSimpsonJLThe overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax200964872873519638566
- PirasBMiravitllesMThe overlap phenotype: the (missing) link between asthma and COPDMultidiscip Respir Med201271822958436
- DisantostefanoRLLiHRubinDBStempelDAWhich patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysisBMJ Open201334pii: e001838
- KitaguchiYKomatsuYFujimotoKHanaokaMKuboKSputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthmaInt J Chron Obstruct Pulmon Dis2012728328922589579
- LouieSZekiAASchivoMThe asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Rev Clin Pharmacol20136219721923473596
- Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
- MiravitllesMSoler-CataluñaJJCalleMSpanish guideline for COPD (GesEPOC). Update 2014Arch Bronconeumol201450Suppl 111624507959
- KoblizekVChlumskyJZindrVCzech Pneumological and Phthisiological SocietyChronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented careBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2013157218920123733084
- KankaanrantaHHarjuTKilpeläinenMDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelinesBasic Clin Pharmacol Toxicol2015116429130725515181
- BarrechegurenMEsquinasCMiravitllesMThe asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challengesCurr Opin Pulm Med2015211747925405671
- HardinMSilvermanEKBarrRGCOPDGene InvestigatorsThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
- MiravitllesMSorianoJBAncocheaJCharacterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health statusRespir Med201310771053106023597591
- MiravitllesMBarrechegurenMRoman-RodríguezMFrequency and characteristics of different clinical phenotypes of COPDThe International Journal of Tuberculosis and Lung Disease201519899299826162367
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- Soler-CataluñaJJMartínez-GarcíaMASánchezLSTorderaMPSánchezPRSevere exacerbations and BODE index: two independent risk factors for death in male COPD patientsRespir Med2009103569269919131231
- EisnerMDTrupinLKatzPPDevelopment and validation of a survey-based COPD severity scoreChest200512761890189715947299
- MiravitllesMLlorCde CastellarRIzquierdoIBaróEDonadoEValidation of the COPD severity score for use in primary care: the NEREA studyEur Respir J200933351952719164354
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
- EstebanCQuintanaJMAburtoMImpact of changes in physical activity on health-related quality of life among patients with COPDEur Respir J201036229230020075059
- MiravitllesMCantoniJNaberanKFactors associated with a low level of physical activity in patients with chronic obstructive pulmonary diseaseLung2014192225926524477375
- BadiaXRosetMMontserratSHerdmanMSequraAThe Spanish version of EuroQol: a description and its applications. European Quality of Life scaleMed Clin (Barc)1999112Suppl 1798510618804
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- HerreroMJBlanchJPeriJMDe PabloJPintorLBulbenaAA validation study of the hospital anxiety and depression scale (HADS) in a Spanish populationGen Hosp Psychiatry200325427728312850660
- MenezesAMMontes de OcaMPérez-PadillaRPLATINO TeamIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
- PirasBFerrarottiILaraBClinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiencyEur Respir J2013421546423222880
- GINA and Global Initiative for Chronic Obstructive Lung Disease (GOLD) [webpage on the Internet]Asthma, COPD, and asthma-COPD overlap syndrome. GINA and Global Initiative for Chronic Obstructive Lung Disease2015 Available from: http://www.goldcopd.org/asthma-copd-overlap.htmlAccessed March 10, 2015
- Izquierdo-AlonsoJLRodriguez-GonzálezmoroJMde Lucas-RamosPPrevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD)Respir Med2013107572473123419828
- GolpeRSanjuán LópezPCano JiménezECastro AñónOPérez de LlanoLADistribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smokeArch Bronconeumol201450831832424576449
- MiravitllesMHuertaAFernández-VillarJAGeneric utilities in chronic obstructive pulmonary disease patients stratified according to different staging systemsHealth Qual Life Outcomes20141212025189786
- RheeCKYoonHKYooKHMedical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthmaCOPD201411216317024111662
- PleasantsRAOharJACroftJBChronic obstructive pulmonary disease and asthma-patient characteristics and health impairmentCOPD201411325626624152212
- IwamotoHGaoJKoskelaJDifferences in plasma and sputum biomarkers between COPD and COPD-asthma overlapEur Respir J201443242142923794464
- BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434
- SivaRGreenRHBrightlingCEEosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEur Respir J200729590691317301099
- BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trialAm J Respir Crit Care Med20121861485522447964
- PascoeSLocantoreNDransfieldMBarnesNCPavordDIBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643542225878028
- MiravitllesMSoler-CataluñaJJCalleMSorianoJBTreatment of COPD by clinical phenotypes: putting old evidence into clinical practiceEur Respir J20134161252125623060631
- MiravitllesMSorianoJBGarcía-RíoFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax2009641086386819553233